See more : Lithium & Boron Technology, Inc. (LBTI) Income Statement Analysis – Financial Results
Complete financial analysis of Jinxin Fertility Group Limited (JXFGF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jinxin Fertility Group Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- BT Group plc (BTGOF) Income Statement Analysis – Financial Results
- Luminex Corporation (LMNX) Income Statement Analysis – Financial Results
- IDenta Corp. (IDTA) Income Statement Analysis – Financial Results
- Keisei Electric Railway Co., Ltd. (9009.T) Income Statement Analysis – Financial Results
- HEP Tech Co., Ltd. (3609.TWO) Income Statement Analysis – Financial Results
Jinxin Fertility Group Limited (JXFGF)
About Jinxin Fertility Group Limited
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.79B | 2.36B | 1.84B | 1.43B | 1.65B | 921.99M | 662.77M | 346.41M |
| Cost of Revenue | 1.61B | 1.45B | 1.07B | 860.31M | 831.70M | 508.88M | 360.64M | 213.69M |
| Gross Profit | 1.18B | 913.13M | 771.48M | 565.78M | 816.80M | 413.12M | 302.14M | 132.72M |
| Gross Profit Ratio | 42.15% | 38.62% | 41.96% | 39.67% | 49.55% | 44.81% | 45.59% | 38.31% |
| Research & Development | 21.75M | 17.47M | 10.65M | 11.48M | 13.30M | 11.98M | 10.31M | 0.00 |
| General & Administrative | 481.37M | 458.85M | 327.73M | 275.26M | 211.30M | 63.11M | 12.13M | 9.89M |
| Selling & Marketing | 191.86M | 151.44M | 61.72M | 41.36M | 62.22M | 0.00 | 1.39M | 905.00K |
| SG&A | 673.23M | 610.29M | 389.45M | 316.62M | 273.51M | 63.11M | 12.13M | 9.89M |
| Other Expenses | 0.00 | 12.38M | 22.45M | 5.84M | 13.17M | 2.89M | 4.88M | 408.00K |
| Operating Expenses | 694.97M | 715.30M | 326.86M | 251.87M | 305.75M | 148.45M | 65.49M | 26.68M |
| Cost & Expenses | 2.31B | 2.17B | 1.39B | 1.11B | 1.14B | 657.32M | 426.13M | 240.37M |
| Interest Income | 20.71M | 43.51M | 13.30M | 35.23M | 36.86M | 9.61M | 1.24M | 20.13M |
| Interest Expense | 79.64M | 71.85M | 21.15M | 13.39M | 9.32M | 45.80M | 100.95M | 17.23M |
| Depreciation & Amortization | 201.55M | 260.00M | 169.17M | 130.29M | 112.55M | 42.27M | 35.35M | 14.29M |
| EBITDA | 682.02M | 476.22M | 494.08M | 331.91M | 609.29M | 319.13M | 278.11M | 140.86M |
| EBITDA Ratio | 24.45% | 20.14% | 26.87% | 23.27% | 36.96% | 34.61% | 41.96% | 40.66% |
| Operating Income | 480.47M | 285.37M | 371.39M | 237.68M | 529.98M | 276.86M | 242.76M | 126.57M |
| Operating Income Ratio | 17.23% | 12.07% | 20.20% | 16.67% | 32.15% | 30.03% | 36.63% | 36.54% |
| Total Other Income/Expenses | -16.21M | -131.04M | 86.54M | 111.45M | 17.92M | -21.11M | -1.18M | -17.23M |
| Income Before Tax | 464.27M | 154.32M | 457.93M | 349.13M | 547.90M | 276.59M | 241.58M | 109.35M |
| Income Before Tax Ratio | 16.65% | 6.53% | 24.90% | 24.48% | 33.24% | 30.00% | 36.45% | 31.57% |
| Income Tax Expense | 117.29M | 36.38M | 104.23M | 88.64M | 127.22M | 64.46M | 43.03M | 5.69M |
| Net Income | 344.72M | 121.12M | 339.90M | 251.62M | 409.62M | 166.60M | 98.78M | 87.58M |
| Net Income Ratio | 12.36% | 5.12% | 18.48% | 17.64% | 24.85% | 18.07% | 14.90% | 25.28% |
| EPS | 0.12 | 0.05 | 0.14 | 0.10 | 0.19 | 0.07 | 0.04 | 0.04 |
| EPS Diluted | 0.13 | 0.05 | 0.14 | 0.10 | 0.19 | 0.07 | 0.04 | 0.04 |
| Weighted Avg Shares Out | 2.81B | 2.50B | 2.48B | 2.40B | 2.20B | 2.37B | 2.37B | 2.37B |
| Weighted Avg Shares Out (Dil) | 2.74B | 2.62B | 2.50B | 2.42B | 2.21B | 2.38B | 2.38B | 2.38B |
Source: https://incomestatements.info
Category: Stock Reports